Biotech Immutep Announces Successful Meeting with the FDA on Eftilagimod Alpha plus Chemotherapy for the Treatment of Metastatic Breast Cancer December 23, 2022
Biotech Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2022 Financial Results and Provides Business Update December 22, 2022
Biotech Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN) December 22, 2022
Biotech Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film) December 22, 2022
Biotech Affimed Announces Approval of Clinical Trial Application in France for a Phase 1 Study of AFM28 in Relapsed/Refractory Acute Myeloid Leukemia December 22, 2022
Biotech CLASS ACTION UPDATE for EIGR, VERU and NBEVQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 21, 2022
Biotech Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation December 21, 2022
Biotech EIGER BIOPHARMACEUTICALS, INC. (NASDAQ:EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) December 21, 2022
Biotech Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property December 21, 2022
Biotech CLASS ACTION UPDATE for FRSH, SEDG and EIGR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 20, 2022
Search
